Search Results

Immunicum AB (publ) Publishes the Annual Report for 2018

Immunicum AB, announced that its Annual Report for 2018 is now available on the company’s website, www.immunicum.com.

April 5, 2019

·

1 min read

Deals

Changes to the Nomination Committee for Immunicum AB (publ)

Immunicum AB announced the composition of the Nomination Committee on 19 October 2018.

January 30, 2019

·

1 min read

Deals

Immunicum AB (publ) Announces Upcoming Investor Events in February 2019

Immunicum AB announced that Carlos de Sousa, CEO of Immunicum, and other members of the management team will present at upcoming investor conferences in February.

February 3, 2019

·

1 min read

Deals

Immunicum AB (publ) Announces Upcoming Conferences in March and April

Immunicum AB announced that members of the management team will attend and present at upcoming conferences in March and April.

March 24, 2019

·

1 min read

Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm

Immunicum AB (publ; IMMU.ST) announced today that the Company will host two investor events in October. At both events, Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session.

October 30, 2018

·

1 min read

Business

Immunicum AB (publ) Year-End Report 2018

Immunicum announced a collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate ilixadencel in combination with Avelumab in multi-indication phase Ib/II study ILIAD.

February 17, 2019

·

6 min read

Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019

At the Annual General Meeting of Immunicum AB (publ), reg. no 556629-1786, on April 25, 2019 the AGM adopted, inter alia, the following resolutions.

April 26, 2019

·

5 min read

Notice of Annual General Meeting in Immunicum AB (publ)

The shareholders of Immunicum AB, reg. no 556629-1786, are hereby invited to the Annual General Meeting on Thursday, 25 April 2019, at 10:30, at Sturegatan 15’s premises, at Sturegatan 15, SE-161 14 36 Stockholm.

March 26, 2019

·

24 min read

Deals

Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Rights Issue

Immunicum AB has, as previously announced, implemented a share issue with preferential rights for the Company’s existing shareholders.

January 31, 2019

·

1 min read

Immunicum AB (publ) Announces Upcoming Investor Events in October and November 2018

Immunicum AB announced today that the Company will participate in and host investor events in October and November.

October 29, 2018

·

2 min read